Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer, DESTINY-PanTumor02, Sacituzumab tirumotecan, Trastuzumab deruxtecan and the tag subtype-page.
Shares Letrozole (and other aromatase inhibitors), Olaparib, Trastuzumab, Trastuzumab deruxtecan and the tag subtype-page.
Shares RAINFOL-01 (Rina-S), Luveltamab tazevibulin, Rinatabart sesutecan, Letrozole (and other aromatase inhibitors) and the tag subtype-page.
Shares Radiotherapy, Brachytherapy, Paclitaxel / nab-paclitaxel, IMRT / IGRT (modern external beam) and the tag subtype-page.
Shares Lenvatinib, Paclitaxel / nab-paclitaxel, IMRT / IGRT (modern external beam), Pembrolizumab and the tag subtype-page.
Shares Letrozole (and other aromatase inhibitors), Paclitaxel / nab-paclitaxel, Carboplatin and the tag subtype-page.
Shares Saruparib, Olaparib, Paclitaxel / nab-paclitaxel, Carboplatin and the tag subtype-page.
Shares Trastuzumab, Trastuzumab deruxtecan, Carboplatin and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.